PropThink: SPPI Strong 3Q; Guidance Raised, Fusilev Growing, Estimates To Rise

[ACN Newswire] – By David MoskowitzSpectrum Pharmaceuticals (NASDAQ:SPPI) reported adjusted 3Q 2012 earnings per share (EPS) of $0.42, beating the Consensus estimate of $0.27. Revenues for the period came in at $69.0 million … more

View todays social media effects on SGNT

View the latest stocks trending across Twitter. Click to view dashboard